Influenza causes a major public health burden, as evidenced by the tremendous efforts required to prevent and treat disease during the recent H1N1 pandemic. The primary influenza prevention method is vaccination;however, the effectiveness of influenza vaccine varies depending upon host factors and vaccine characteristics that include individual immune response and the match between the vaccine strains and circulating strains in any given year. Therefore, vaccine effectiveness (VE) varies annually, particularly among elderly persons, and is a subject of international controversy. We propose an age-matched case-control study of the effectiveness of influenza vaccine in the UPMC- Health System. Using case-control methods, we propose to calculate the effectiveness of influenza vaccines against laboratory-confirmed influenza virus infections among outpatients in three age groups: 6 months-18 yrs, 19-49 yrs, and 50+yrs. We will use existing syndromic surveillance to identify when influenza-like illness (ILI) begins in the community;recruit, consent and enroll outpatients with for medically-attended acute respiratory illness (MAARI);test with reverse transcriptase-polymerase chain reaction (RT-PCR) to identify cases and controls;determine vaccination status using primarily the UPMC electronic health record (EHR) and the electronic statewide vaccine registry (PA-SIIS);quantify potential confounders and effect modifiers using the EHR (e.g., Charleson co-morbidity score) and survey methodology;determine VE;and conduct sensitivity analyses about the impact of potential unmeasured confounders. Additionally we will determine the local epidemiology, burden and course of influenza illness and estimate the population-based attack rate for laboratory-confirmed influenza, using agent-based modeling at the Pittsburgh Supercomputing Center. The proposed study is based on a strong foundation of our ongoing syndromic surveillance of influenza, advanced biomedical informatics using system-wide electronic medical record, broadly-based research to increase vaccination rates, clinical context of multiplex respiratory virus testing, and agent-based modeling to produce population estimates of disease burden and cost and involves a well-published team of investigators.
The effectiveness of influenza vaccine is controversial due to lack of laboratory- confirmed endpoints and confounding. We propose a case-control study in the UPMC Health System comparing the effectiveness of influenza vaccine against laboratory- confirmed influenza among children and adults who present for care, comparing vaccination status and adjusting for confounders. Agent based modeling will be used for evaluate population disease burden. Real-time disease surveillance will be used to track the influenza season.
|Russell, Kate; Chung, Jessie R; Monto, Arnold S et al. (2018) Influenza vaccine effectiveness in older adults compared with younger adults over five seasons. Vaccine 36:1272-1278|
|Shang, Mei; Chung, Jessie R; Jackson, Michael L et al. (2018) Influenza vaccine effectiveness among patients with high-risk medical conditions in the United States, 2012-2016. Vaccine 36:8047-8053|
|Martin, Judith M; Avula, Raghunandan; Nowalk, Mary Patricia et al. (2018) Inflammatory Mediator Expression Associated With Antibody Response Induced by Live Attenuated vs Inactivated Influenza Virus Vaccine in Children. Open Forum Infect Dis 5:ofy277|
|Jackson, Michael L; Phillips, C Hallie; Benoit, Joyce et al. (2018) Burden of medically attended influenza infection and cases averted by vaccination - United States, 2013/14 through 2015/16 influenza seasons. Vaccine 36:467-472|
|Jackson, Michael L; Chung, Jessie R; Jackson, Lisa A et al. (2017) Influenza Vaccine Effectiveness in the United States during the 2015-2016 Season. N Engl J Med 377:534-543|
|Cole, Kelly Stefano; Martin, Judith M; Horne, William T et al. (2017) Differential gene expression elicited by children in response to the 2015-16 live attenuated versus inactivated influenza vaccine. Vaccine 35:6893-6897|
|Kim, Jin Hyang; Mishina, Margarita; Chung, Jessie R et al. (2016) Cell-Mediated Immunity Against Antigenically Drifted Influenza A(H3N2) Viruses in Children During a Vaccine Mismatch Season. J Infect Dis 214:1030-8|
|Spencer, Sarah; Chung, Jessie; Thompson, Mark et al. (2016) Factors associated with real-time RT-PCR cycle threshold values among medically attended influenza episodes. J Med Virol 88:719-23|
|Petrie, Joshua G; Cheng, Caroline; Malosh, Ryan E et al. (2016) Illness Severity and Work Productivity Loss Among Working Adults With Medically Attended Acute Respiratory Illnesses: US Influenza Vaccine Effectiveness Network 2012-2013. Clin Infect Dis 62:448-455|
|Flannery, Brendan; Zimmerman, Richard K; Gubareva, Larisa V et al. (2016) Enhanced Genetic Characterization of Influenza A(H3N2) Viruses and Vaccine Effectiveness by Genetic Group, 2014-2015. J Infect Dis 214:1010-9|
Showing the most recent 10 out of 27 publications